Skip to content

Bio Impedance Electrical Analysis to Predict Outcome After Cardiac Surgery

Bio Impedance Electrical Analysis to Predict Outcome After Cardiac Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05229159
Acronym
BiPOCS
Enrollment
220
Registered
2022-02-08
Start date
2021-07-01
Completion date
2021-11-30
Last updated
2022-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Care After Cardiac Surgery With Cardio Pulmonary Bypass

Keywords

phase angle, cardiac surgery, cardiopulmonary bypass, risk stratification, outcomes

Brief summary

Phase angle determined by bioelectrical impedance analysis is a strong prognostic factor in several medical areas as clinical nutrition, nephrology, infectious disease, oncology. Inflammation, frailty status and fluid overload can lead to a phase angle decreased. Some studies support its use for risk stratification in intensive care unit and other in preoperative for cardiac surgery. The investigators would like to evaluate its relevance for risk stratification at intensive care unit admission in the context of postoperative cardiac surgery with cardiopulmonary bypass.

Interventions

Segmental multi-frequency bioelectrical impedance analysis are carried out at all patient admitted to our ICU for postoperative care after cardiac surgery with cardiopulmonary bypass. Our objective is to evaluate the relevance of phase angle to predict mortality or a prolonged hospital length of stay. Phase angle is evaluated at ICU admission and will be compared to well-known prognostic scores computed in preoperative (EuroSCORE II) and at day one after surgery (SOFA, CASUS and SAPS II).

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age higher than 18 * Cardiac surgery with cardiopulmonary bypass * Bioelectrical impedance analysis the day of the admission in intensive care unit

Exclusion criteria

* Left ventricular assist device * Limitations des thérapeutiques actives en place pour le patient * Patient opposition to the use of his health data * Invalid bioelectrical impedance analysis * Advanced directives to withhold or withdraw life-sustaining treatment

Design outcomes

Primary

MeasureTime frameDescription
Area under the receiver operating characteristic curve to predict a composite criterion including in-hospital mortality or prolonged hospital length of stay.at 6 months after the cardiac surgeryThe phase angle's area under the receptor operative curve to predict a composite criteria evaluated at hospital discharge and combining: * In hospital mortality * Prolonged hospital length of stay, defined by an in hospital length of stay greater than the 75th percentile of length of stay in the study population

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026